Skip to Content

125 GG 337 (Levothyroxine Sodium 125 mcg (0.125 mg))

Pill with imprint 125 GG 337 is Beige, Capsule-shape and has been identified as Levothyroxine Sodium 125 mcg (0.125 mg). It is supplied by Sandoz Pharmaceuticals Inc..

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 125 mcg (0.125 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for 125 GG 337

Levothyroxine sodium 125 mcg (0.125 mg) 125 GG 337 Front
Levothyroxine sodium 125 mcg (0.125 mg) 125 GG 337 Back
Levothyroxine sodium 125 mcg (0.125 mg) 125 GG 337
Levothyroxine sodium 125 mcg (0.125 mg) 125 GG 337

Levothyroxine Sodium

Imprint:
125 GG 337
Strength:
125 mcg (0.125 mg)
Color:
Beige
Size:
9.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
silicon dioxide
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide